This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

XIV. Failure of Aureomycin to Affect the Course of Ocular Tuberculosis

ALAN C. WOODS, M.D.; RONALD M. WOOD, Ph.D.; HOWARD A. NAQUIN, M.D.

Arch Ophthal. 1950;43(5):845-848.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AUREOMYCIN has been shown to be successful in the treatment of a wide variety of infectious diseases.¹ It has also been shown that resistance to aureomycin by many organisms is developed much more slowly and to a less degree than is resistance to streptomycin.² Braley and Sanders³ reported 2 cases of tuberculous uveitis in which decided improvement followed treatment with aureomycin. Schoenbach⁴ treated 6 patients with various forms of tuberculosis. Two of these 6 showed improvement, 1 with a renal infection, the other with scrofulous draining sinuses of the neck.

Steenken and Wolinsky⁵ found the in vitro sensitivity of the H37 RV strain of Mycobacterium tuberculosis to vary from 5 to 40 micrograms per cubic centimeter, depending on the medium used for the assay. These authors treated the disease in guinea pigs with aureomycin and concluded that the course of the clinical disease was not . . . [Full Text PDF of this Article]

Author Affiliations
BALTIMORE

From the Wilmer Ophthalmological Institute of the Johns Hopkins Hospital and University.

Footnotes
This investigation was supported in part by a grant from the John and Mary R. Markle Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?